Inventor · disambiguated record
Ida Hiemstra
Also filed as: HIEMSTRA IDA
4 granted patents·5 pending applications·18 citations·filing 2021–2023
72Inventor score
Files withGENMAB AS9
Top patents by PatentIndex Score
9 records- 0196US11608383B2Bispecific antibody against CD3 and CD20 in combination therapy for treating follicular lymphomaGENMAB AS·Filed 2021·Granted Mar 21, 2023·8 cites·30 claims
- 0295US11845805B2Bispecific antibody against CD3 and CD20 in combination therapy for treating diffuse large B-cell lymphomaGENMAB AS·Filed 2021·Granted Dec 19, 2023·5 cites·33 claims
- 0393US11858995B2Bispecific antibodies against CD3 and CD20 for treating chronic lymphocytic leukemiaGENMAB AS·Filed 2021·Granted Jan 2, 2024·4 cites·28 claims
- 0478US12435154B2Bispecific antibodies against CD3 and CD20GENMAB AS·Filed 2021·Granted Oct 7, 2025·1 cites·29 claims
- 0578US2024301078A1Bispecific antibody against cd3 and cd20 in combination therapy for treating diffuse large b-cell lymphomaGENMAB AS·Filed 2023·Application pending·0 cites
- 0668US2024034812A1Bispecific antibody against cd3 and cd20 in combination therapy for treating diffuse large b-cell lymphomaGENMAB AS·Filed 2021·Application pending·0 cites
- 0763US2023312758A1Bispecific antibody against cd3 and cd20 in combination therapy for treating follicular lymphomaGENMAB AS·Filed 2021·Application pending·0 cites
- 0861US2023312757A1Bispecific antibodies against cd3 and cd20 for treating chronic lymphocytic leukemiaGENMAB AS·Filed 2021·Application pending·0 cites
- 0957US2025382378A1Cd38 antibodies and uses thereofGENMAB AS·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ida Hiemstra files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →